Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A diol-containing biomolecule is a broad category referring to biomolecules that feature two hydroxyl (-OH) groups within their chemical structure; this can refer to a diverse range of compounds, including carbohydrates (such as saccharides), nucleosides, nucleotides, and some glycoproteins[2][4]. These biomolecules are not themselves a single molecular target, but rather are defined by the presence of a diol functional group. Many analytical chemistries, notably boronate affinity chromatography, exploit this chemical feature for the capture or detection of these molecules, especially "cis-diol-containing" biomolecules (where the two -OH groups are on adjacent carbons and oriented cis to each other)[4]. Diol functionalities are central in carbohydrate chemistry, and their role is mainly structural, as part of the backbone of sugars, glycosylated proteins, and nucleic acids. There are no known drugs that specifically "target" diol-containing biomolecules as a class; however, boronic acids can bind diols, a property used in affinity purification and biosensing[4]. Key caveats: - This term is not a singular, well-defined biological target; instead, it refers to a chemical motif found in many molecules. - There is no canonical abbreviation, no specific role as a therapeutic target, no clinical biomarkers, and no directly interacting drugs as for classic molecular targets. - If your workflow expects discrete protein, enzyme, or receptor targets, this entry should be flagged as "incorrect" or "too generic/ambiguous"[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Diol-containing biomolecule.